Erin M. Lavelle

Insider Reports History

Entity
Individual
Location
360 1616 Eastlake Avenue East, Seattle, WA
Signature
/s/ Kris McGrew, Attorney-in-Fact for Erin M. Lavelle
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erin M. Lavelle:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Neoleukin Therapeutics, Inc. Director Stock Option (Right to Buy) 25K May 11, 2021 Direct

Insider Reports Filed by Erin M. Lavelle

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NLTX Neoleukin Therapeutics, Inc. May 11, 2021 1 $0 4 May 13, 2021 Director